155 related articles for article (PubMed ID: 25129125)
21. Selected immuno-histochemical markers in curettage specimens and their correlation with final pathologic findings in endometrial cancer patients.
Obeidat BR; Matalka II; Mohtaseb AA; Al-Kaisi NS
Pathol Oncol Res; 2013 Apr; 19(2):229-35. PubMed ID: 23055021
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical expression of cancer stem cell related markers CD44 and CD133 in endometrial cancer.
Elbasateeny SS; Salem AA; Abdelsalam WA; Salem RA
Pathol Res Pract; 2016 Jan; 212(1):10-6. PubMed ID: 26608413
[TBL] [Abstract][Full Text] [Related]
23. The value of ultrasonography in preoperative assessment of selected prognostic factors in endometrial cancer.
Sawicki W; Spiewankiewicz B; Stelmachów J; Cendrowski K
Eur J Gynaecol Oncol; 2003; 24(3-4):293-8. PubMed ID: 12807243
[TBL] [Abstract][Full Text] [Related]
24. [Pertinence of the preoperative exploration in the evaluation of the risk of lymph node metastasis in endometrial cancer].
Groff B; Pouget O; Stoll F; Mathelin C; Baldauf JJ; Akladios CY
Gynecol Obstet Fertil; 2014 Feb; 42(2):92-96. PubMed ID: 24309027
[TBL] [Abstract][Full Text] [Related]
25. [Prognostic factors in diagnosed endometrial cancers determining the type of radical surgery].
Ivanov S; Tomov S
Akush Ginekol (Sofiia); 2009; 48(3):14-9. PubMed ID: 20198758
[TBL] [Abstract][Full Text] [Related]
26. Comparison of myometrial invasion and tumor free distance from uterine serosa in endometrial cancer.
Ozbilen O; Sakarya DK; Bezircioglu I; Kasap B; Yetimalar H; Yigit S
Asian Pac J Cancer Prev; 2015; 16(2):519-22. PubMed ID: 25684481
[TBL] [Abstract][Full Text] [Related]
27. The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology.
Chi DS; Barakat RR; Palayekar MJ; Levine DA; Sonoda Y; Alektiar K; Brown CL; Abu-Rustum NR
Int J Gynecol Cancer; 2008; 18(2):269-73. PubMed ID: 18334008
[TBL] [Abstract][Full Text] [Related]
28. Does the use of the 2009 FIGO classification of endometrial cancer impact on indications of the sentinel node biopsy?
Ballester M; Koskas M; Coutant C; Chéreau E; Seror J; Rouzier R; Daraï E
BMC Cancer; 2010 Aug; 10():465. PubMed ID: 20804553
[TBL] [Abstract][Full Text] [Related]
29. Expression of astrocyte elevated gene-1: a novel marker of the pathogenesis, progression, and poor prognosis for endometrial cancer.
Song H; Li C; Lu R; Zhang Y; Geng J
Int J Gynecol Cancer; 2010 Oct; 20(7):1188-96. PubMed ID: 21495225
[TBL] [Abstract][Full Text] [Related]
30. High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma.
Stelloo E; Nout RA; Naves LC; Ter Haar NT; Creutzberg CL; Smit VT; Bosse T
Gynecol Oncol; 2014 May; 133(2):197-204. PubMed ID: 24556061
[TBL] [Abstract][Full Text] [Related]
31. Pathological findings in early-stage endometrial cancer.
Zehavi S; Schneider D; Bukovsky I; Halperin R
Eur J Gynaecol Oncol; 2003; 24(1):18-20. PubMed ID: 12691310
[TBL] [Abstract][Full Text] [Related]
32. Differential expression of Oct-4, CD44, and E-cadherin in eutopic and ectopic endometrium in ovarian endometriomas and their correlations with clinicopathological variables.
Sancakli Usta C; Turan G; Bulbul CB; Usta A; Adali E
Reprod Biol Endocrinol; 2020 Nov; 18(1):116. PubMed ID: 33218351
[TBL] [Abstract][Full Text] [Related]
33. A modern assessment of the surgical pathologic spread and nodal dissemination of endometrial cancer.
Praiss AM; Huang Y; St Clair CM; Tergas AI; Melamed A; Khoury-Collado F; Hou JY; Hur C; Ananth CV; Neugut AI; Hershman DL; Wright JD
Gynecol Oncol; 2020 May; 157(2):329-334. PubMed ID: 32094021
[TBL] [Abstract][Full Text] [Related]
34. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
35. Proliferating cell nuclear antigen in endometrial carcinoma: pretreatment identification of high-risk patients.
Garzetti GG; Ciavattini A; Goteri G; De Nictolis M; Romanini C
Gynecol Oncol; 1996 Apr; 61(1):16-21. PubMed ID: 8626110
[TBL] [Abstract][Full Text] [Related]
36. Nomogram to Predict Risk of Lymph Node Metastases in Patients With Endometrioid Endometrial Cancer.
Pollom EL; Conklin CM; von Eyben R; Folkins AK; Kidd EA
Int J Gynecol Pathol; 2016 Sep; 35(5):395-401. PubMed ID: 26598977
[TBL] [Abstract][Full Text] [Related]
37. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
38. Assessment of endometrial sampling as a predictor of final surgical pathology in endometrial cancer.
Helpman L; Kupets R; Covens A; Saad RS; Khalifa MA; Ismiil N; Ghorab Z; Dubé V; Nofech-Mozes S
Br J Cancer; 2014 Feb; 110(3):609-15. PubMed ID: 24366295
[TBL] [Abstract][Full Text] [Related]
39. Alteration of CD44 and cadherins expression: possible association with augmented aggressiveness and invasiveness of endometrial carcinoma.
Leblanc M; Poncelet C; Soriano D; Walker-Combrouze F; Madelenat P; Scoazec JY; Darai E
Virchows Arch; 2001 Jan; 438(1):78-85. PubMed ID: 11213839
[TBL] [Abstract][Full Text] [Related]
40. Accuracy of tumor grade by preoperative curettage and associated clinicopathologic factors in clinical stage I endometriod adenocarcinoma.
Wang XY; Pan ZM; Chen XD; Lü WG; Xie X
Chin Med J (Engl); 2009 Aug; 122(16):1843-6. PubMed ID: 19781357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
